Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 515138-06-4
2. Fonadelpar [usan]
3. Nps-005
4. Sjp-0035
5. Fk5zad810z
6. 2-((3-(2-(4-isopropyl-2-(4-(trifluoromethyl)phenyl)thiazol-5-yl)ethyl)-5-methylbenzo[d]isoxazol-6-yl)oxy)acetic Acid
7. 2-[[5-methyl-3-[2-[4-propan-2-yl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethyl]-1,2-benzoxazol-6-yl]oxy]acetic Acid
8. Acetic Acid, 2-((5-methyl-3-(2-(4-(1-methylethyl)-2-(4-(trifluoromethyl)phenyl)-5-thiazolyl)ethyl)-1,2-benzisoxazol-6-yl)oxy)-
9. Unii-fk5zad810z
10. Fonadelpar [inn]
11. Fonadelpar (usan/inn)
12. Fonadelpar [who-dd]
13. Schembl1765984
14. Chembl3545186
15. Wwkylbgqyaledl-uhfffaoysa-n
16. Akos040741758
17. Sb18835
18. Hy-17633
19. Cs-0016824
20. D10880
21. (3-(2-(4-isopropyl-2-(4-(trifluoromethyl)phenyl)-5-thiazolyl)ethyl-5-methyl-1,2-benzisoxazol-6-yl)oxyacetic Acid
22. 2-((5-methyl-3-(2-(4-(1-methylethyl)-2-(4-(trifluoromethyl)phenyl)thiazol-5-yl)ethyl)-1,2-benzisoxazol-6-yl)oxy)acetic Acid
Molecular Weight | 504.5 g/mol |
---|---|
Molecular Formula | C25H23F3N2O4S |
XLogP3 | 6.7 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 8 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 114 |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 719 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
70
PharmaCompass offers a list of Fonadelpar API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fonadelpar manufacturer or Fonadelpar supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fonadelpar manufacturer or Fonadelpar supplier.
PharmaCompass also assists you with knowing the Fonadelpar API Price utilized in the formulation of products. Fonadelpar API Price is not always fixed or binding as the Fonadelpar Price is obtained through a variety of data sources. The Fonadelpar Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fonadelpar manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fonadelpar, including repackagers and relabelers. The FDA regulates Fonadelpar manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fonadelpar API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fonadelpar supplier is an individual or a company that provides Fonadelpar active pharmaceutical ingredient (API) or Fonadelpar finished formulations upon request. The Fonadelpar suppliers may include Fonadelpar API manufacturers, exporters, distributors and traders.
click here to find a list of Fonadelpar suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fonadelpar DMF (Drug Master File) is a document detailing the whole manufacturing process of Fonadelpar active pharmaceutical ingredient (API) in detail. Different forms of Fonadelpar DMFs exist exist since differing nations have different regulations, such as Fonadelpar USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fonadelpar DMF submitted to regulatory agencies in the US is known as a USDMF. Fonadelpar USDMF includes data on Fonadelpar's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fonadelpar USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fonadelpar suppliers with USDMF on PharmaCompass.
Fonadelpar Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fonadelpar GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fonadelpar GMP manufacturer or Fonadelpar GMP API supplier for your needs.
A Fonadelpar CoA (Certificate of Analysis) is a formal document that attests to Fonadelpar's compliance with Fonadelpar specifications and serves as a tool for batch-level quality control.
Fonadelpar CoA mostly includes findings from lab analyses of a specific batch. For each Fonadelpar CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fonadelpar may be tested according to a variety of international standards, such as European Pharmacopoeia (Fonadelpar EP), Fonadelpar JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fonadelpar USP).